{"acquisitions":[],"changes":[],"country":"US","description":"Proxima is an AI drug discovery company building medicines that modulate protein-to-protein interactions rather than toggling single proteins. It serves biopharma targeting diseases long considered undruggable. Its edge is pairing its NeoLink data engine with Neo AI models to discover proximity-modulating small molecules.","domain":"proxima.bio","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":52.197585,"lng":0.139154,"location":"Cambridge","multiples":[],"name":"Proxima","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":80000000,"connectionsAmong":[],"currency":"USD","date":"2026-01-13","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"proxima-bio-2026-01-13-venture","source":{"fact":"round","publisher":"news-misc","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"proxima-bio","sources":[{"fact":"round","publisher":"news-misc","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"proxima.bio","retrievedAt":"2026-05-07","status":"self-reported","url":"https://proxima.bio"},{"fact":"description","publisher":"proxima.bio","retrievedAt":"2026-05-07","status":"self-reported","url":"https://proxima.bio"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":80000000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}